(Q38162490)

30 August 2017

title

Definitions of and contributions to cardiovascular disease in systemic lupus erythematosus (English)

1 reference

systemic lupus erythematosus

30 August 2017

main subject

cardiovascular disease

1 reference

based on heuristic

inferred from title

0 references

Elisabet Svenungsson

2

0 references

author name string

Johanna T Gustafsson

series ordinal

1

1 reference

30 August 2017

publication date

14 November 2013

1 reference

30 August 2017

1 reference

30 August 2017

volume

47

1 reference

30 August 2017

issue

2

1 reference

30 August 2017

page(s)

67-76

1 reference

Understanding the epidemiology and progression of systemic lupus erythematosus

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Predictors of survival in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Changing patterns in mortality and disease outcomes for patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Risk factors for cardiovascular mortality in patients with systemic lupus erythematosus, a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Mortality in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

A multicentre study of 513 Danish patients with systemic lupus erythematosus. II. Disease mortality and clinical factors of prognostic value.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Damage and mortality in a group of British patients with systemic lupus erythematosus followed up for over 10 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Causes and predictors of death in South Africans with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Survival in systemic lupus erythematosus, 1995-2010. A prospective study in a Danish community

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Systemic lupus erythematosus and the risk of cardiovascular disease: results from the nurses' health study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Cardiovascular event in systemic lupus erythematosus in northern Sweden: incidence and predictors in a 7-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

High plasma leptin levels confer increased risk of atherosclerosis in women with systemic lupus erythematosus, and are associated with inflammatory oxidised lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Premature coronary-artery atherosclerosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

C-reactive protein and coronary artery calcium in asymptomatic women with systemic lupus erythematosus or rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Carotid intima–media thickness: a suitable alternative for cardiovascular risk as outcome?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Longitudinal study on premature atherosclerosis in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Carotid atherosclerosis, vascular risk profile and mortality in a population-based sample of functionally healthy elderly subjects: the Berlin ageing study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

A STAT4 risk allele is associated with ischaemic cerebrovascular events and anti-phospholipid antibodies in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Incidence of and risk factors for adverse cardiovascular events among patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Predictors of progression in atherosclerosis over 2 years in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Lymphopenia is a risk factor in the progression of carotid intima-media thickness in juvenile-onset systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Rate and determinants of progression of atherosclerosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Factors involved in the progress of preclinical atherosclerosis associated with systemic lupus erythematosus: a 2-year longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Progression of carotid intima-media thickness and plaque in women with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

The role of carotid arterial intima-media thickness in predicting clinical coronary events

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Predictors of cardiovascular damage in patients with systemic lupus erythematosus: data from LUMINA (LXVIII), a multiethnic US cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Risk factors for clinical coronary heart disease in systemic lupus erythematosus: the lupus and atherosclerosis evaluation of risk (LASER) study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Dysfunctional proinflammatory high-density lipoproteins confer increased risk of atherosclerosis in women with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII. Baseline predictors of vascular events.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Factors associated with coronary artery calcification in young female patients with SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Effects of tobacco smoke on immunity, inflammation and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Smoking as a trigger for inflammatory rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Cigarette smoking and systemic lupus erythematosus: a smoking gun?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Association of smoking with dsDNA autoantibody production in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Frequency of antibodies to the cholesterol transport protein apolipoprotein A1 in patients with SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

TNF-alpha: a link between hypertriglyceridaemia and inflammation in SLE patients with cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Risk factors for cardiovascular disease in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Anti-oxidized low-density-lipoprotein (OxLDL) antibodies in systemic lupus erythematosus with and without antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXVIII. Factors predictive of thrombotic events

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Reduced flow-mediated vasodilation as a marker for cardiovascular complications in lupus patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Endothelium-dependent but not endothelium-independent flow-mediated dilation is significantly reduced in patients with systemic lupus erythematosus without vascular events: a metaanalysis and metaregression.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Levels of soluble VCAM-1, soluble ICAM-1, and soluble E-selectin during disease exacerbations in patients with systemic lupus erythematosus (SLE); a long term prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Traditional and non traditional risk factors in accelerated atherosclerosis in systemic lupus erythematosus: role of vascular endothelial growth factor (VEGATS Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Association of plasma soluble E-selectin and adiponectin with carotid plaque in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Adhesion molecules and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Relationship between lupus nephritis activity and the serum level of soluble VCAM-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

von Willebrand factor in cardiovascular disease: focus on acute coronary syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Increased release of von Willebrand factor antigen from endothelial cells by anti-DNA autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

C-reactive protein and risk of cardiovascular disease: evidence and clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Inflammatory bio-markers and cardiovascular risk prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Risk factors for development of coronary artery disease in women with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

The type I interferon system in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

The type I interferon system in the development of lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Premature vascular damage in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Platelet transcriptional profile and protein expression in patients with systemic lupus erythematosus: up-regulation of the type I interferon system is strongly associated with vascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Serum cystatin C as an endogenous marker of renal function in patients with mild to moderate impairment of kidney function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Cystatin C and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Cystatin C and the risk of death and cardiovascular events among elderly persons

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Cystatin-C and inflammatory markers in the ambulatory elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Association of cystatin C and estimated GFR with inflammatory biomarkers: the Heart and Soul Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Cystatin C influences the autoimmune but not inflammatory response to cartilage type II collagen leading to chronic arthritis development

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Cystatin C is associated with inflammation but not atherosclerosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

The association of antibodies to cardiolipin, beta 2-glycoprotein I, prothrombin, and oxidized low-density lipoprotein with thrombosis in 292 patients with familial and sporadic systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Risk and protective factors for thrombosis in systemic lupus erythematosus: results from a large, multi-ethnic cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Factors predictive of thrombotic events in LUMINA, a multi-ethnic cohort of SLE patients (LXXII).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

HLA-DRB1*04/*13 alleles are associated with vascular disease and antiphospholipid antibodies in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Systemic lupus erythematosus risk factors for coronary artery calcifications.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

The lupus anticoagulant is a risk factor for myocardial infarction (but not atherosclerosis): Hopkins Lupus Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

HLA class II alleles associations of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Specificity of the STAT4 genetic association for severe disease manifestations of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

A risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Association of mannose-binding lectin polymorphisms with sepsis and fatal outcome, in patients with systemic inflammatory response syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

The role of mannose-binding lectin in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Mannose-binding lectin polymorphisms and susceptibility to infection in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Mannose-binding lectin variant alleles and the risk of arterial thrombosis in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Association of mannose-binding lectin gene polymorphisms with antiphospholipid syndrome, cardiovascular disease and chronic damage in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Role of the Fcgamma receptor IIA polymorphism in the antiphospholipid syndrome: an international meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Systemic lupus erythematosus in a multiethnic US Cohort (LUMINA). XXX: association between C-reactive protein (CRP) gene polymorphisms and vascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Prevalence of conventional and lupus-specific risk factors for cardiovascular disease in patients with systemic lupus erythematosus: A case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Current causes of death in systemic lupus erythematosus in Europe, 2000--2004: relation to disease activity and damage accrual.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

A multicentre study of 513 Danish patients with systemic lupus erythematosus. I. Disease manifestations and analyses of clinical subsets.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

High risk of ischemic heart disease in patients with lupus nephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Premature atherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Atherosclerotic plaque in carotid arteries in systemic lupus erythematosus: frequency and associated risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Arterial stiffness in chronic inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Cardiovascular risk scores and the presence of subclinical coronary artery atherosclerosis in women with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Major histocompatibility complex associations with primary antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Subclinical atherosclerosis in systemic lupus erythematosus (SLE): the relative contribution of classic risk factors and the lupus phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

Endothelial function and markers of endothelial activation in relation to cardiovascular disease in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.856005

10.3109/08916934.2013.856005

21 January 2018

Identifiers

DOI

1 reference

30 August 2017

1 reference